Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-11-10 4:56 pm Unchanged | 13D | CAZOO GROUP LTD OCT 2023 CZOO | VIKING GLOBAL INVESTORS LP | 60,000,000 7.3% | 0 (Unchanged) | View |
| 2022-11-03 5:13 pm Purchase | 13D | Frazier Lifesciences Acquisition Corp FLAC | VIKING GLOBAL INVESTORS LP | 3,671,462 25.67% | 847,062 (+29.99%) | View |
| 2022-11-02 08:22 am Purchase | 13G | Frazier Lifesciences Acquisition Corp FLAC | VIKING GLOBAL INVESTORS LP | 2,824,400 19.75% | 2,824,400 (New Position) | View |
| 2022-10-07 5:29 pm Purchase | 13G | Trevi Therapeutics Inc. TRVI | VIKING GLOBAL INVESTORS LP | 5,984,734 9.99% | 5,984,734 (New Position) | View |
| 2022-09-19 5:08 pm Purchase | 13D | CAZOO GROUP LTD OCT 2023 CZOO | VIKING GLOBAL INVESTORS LP | 60,000,000 7.3% | 60,000,000 (New Position) | View |
| 2022-09-09 9:50 pm Sale | 13G | Amylyx Pharmaceuticals Inc. AMLX | VIKING GLOBAL INVESTORS LP | 5,770,536 9.9% | -1,400,000 (-19.52%) | View |
| 2022-07-01 5:00 pm Purchase | 13G | Ginkgo Bioworks Holdings Inc. DNA | VIKING GLOBAL INVESTORS LP | 115,084,128 9.7% | 64,028,984 (+125.41%) | View |
| 2022-06-10 4:15 pm Purchase | 13G | CELLDEX THERAPEUTICS INC C CLDX | VIKING GLOBAL INVESTORS LP | 2,366,385 5.1% | 2,366,385 (New Position) | View |
| 2022-05-20 4:15 pm Purchase | 13G | PepGen Inc. PEPG | VIKING GLOBAL INVESTORS LP | 1,793,923 8% | 1,793,923 (New Position) | View |
| 2022-04-14 5:09 pm Purchase | 13G | STANDARD BIOTOOLS INC. LAB | VIKING GLOBAL INVESTORS LP | 8,103,527 9.5% | 8,103,527 (New Position) | View |
| 2022-03-22 5:18 pm Sale | 13G | PROCEPT BioRobotics Corp PRCT | VIKING GLOBAL INVESTORS LP | 3,658,892 8.4% | -1,249,000 (-25.45%) | View |
| 2022-03-04 5:21 pm Sale | 13D | Ginkgo Bioworks Holdings Inc. DNA | VIKING GLOBAL INVESTORS LP | 51,055,144 4.99% | -251,887,830 (-83.15%) | View |
| 2022-02-14 5:03 pm Sale | 13G | Nuance Communications Inc. SSFT | VIKING GLOBAL INVESTORS LP | 0 0% | -14,347,016 (Position Closed) | View |
| 2022-02-14 5:03 pm Sale | 13G | FIGS Inc. FIGS | VIKING GLOBAL INVESTORS LP | 13,340,414 8.8% | -1,602,275 (-10.72%) | View |
| 2022-02-14 5:02 pm Unchanged | 13G | 4D Molecular Therapeutics Inc. FDMT | VIKING GLOBAL INVESTORS LP | 3,937,914 12.3% | 0 (Unchanged) | View |
| 2022-02-14 5:02 pm Purchase | 13G | Orion Acquisition Corp. OHPA | VIKING GLOBAL INVESTORS LP | 3,669,272 8.9% | 3,669,272 (New Position) | View |
| 2022-02-14 5:02 pm Unchanged | 13G | Adaptive Biotechnologies Corp ADPT | VIKING GLOBAL INVESTORS LP | 29,993,708 21.3% | 0 (Unchanged) | View |
| 2022-02-14 5:02 pm Sale | 13G | Athira Pharma Inc. ATHA | VIKING GLOBAL INVESTORS LP | 0 0% | -2,120,653 (Position Closed) | View |
| 2022-02-14 5:02 pm Unchanged | 13G | Inhibrx Inc. INBX | VIKING GLOBAL INVESTORS LP | 5,305,866 14% | 0 (Unchanged) | View |
| 2022-02-14 5:02 pm Sale | 13G | Edgewise Therapeutics Inc. EWTX | VIKING GLOBAL INVESTORS LP | 2,727,249 5.5% | -625,032 (-18.64%) | View |